VPN Plus+ ExclusiveLess Fear, More Hope: How Research is Driving New Strategies in Hemangiosarcoma Treatment and PreventionDecember 11, 2025In this session: Antonella Borgatti, DVM, MS, DACVIM (Oncology), DECVIM-CA, enlightens attendees with original research from the University of Minnesota on eBAT, a first-in-class bispecific targeted angiotoxin. eBAT is designed to selectively eliminate tumor cells and tumor-initiating cells, offering dual potential as both a therapeutic and preventive option in high-risk canine populations.
Education Center - SponsoredReclaiming Lost Hours: How Digital Prescription Management Is Reshaping Veterinary Workflowsby • MWI Animal HealthAs administrative burdens grow, digital prescription management offers veterinary teams a path to greater efficiency, fewer errors, and more time for patient care.
